Yi Kathy Insider Trades

Insider Trading History

Track insider trading activity for Yi Kathy. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Theseus Pharmaceuticals
Theseus Pharmaceuticals THRX
Director
Holding Value $0 0 shares
Last Trade
Feb 14, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$402k 99,634 shares
$4.03
$4.06
Theseus Pharmaceuticals
Theseus Pharmaceuticals THRX
Director
Holding Value $79.3k 19,500 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$187k 19,500 shares
$9.61
$4.06
Theseus Pharmaceuticals
Theseus Pharmaceuticals THRX
Director
Holding Value $122k 30,000 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 30,000 shares
$5.75
$4.06
Theseus Pharmaceuticals
Theseus Pharmaceuticals THRX
Director
Holding Value $0 0 shares
Last Trade
Oct 06, 2021 Sale
No data
No data
$4.06
Theseus Pharmaceuticals
Theseus Pharmaceuticals THRX
Director
Holding Value $92.2k 22,678 shares
Last Trade
Oct 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.06
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Chief Financial Officer
Holding Value $9.74M 216,718 shares
Last Trade
Feb 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.75M 216,718 shares
$12.70
$44.96
CEREVEL THERAPEUTC HOLDN EQY WARRANT
CEREVEL THERAPEUTC HOLDN EQY WARRANT CEREW
Chief Financial Officer
Holding Value $3.91M 216,718 shares
Last Trade
Feb 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$808k 216,718 shares
$3.73
$18.06
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Chief Financial Officer
Holding Value $3.53M 78,534 shares
Last Trade
Oct 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$776k 78,534 shares
$9.88
$44.96
CEREVEL THERAPEUTC HOLDN EQY WARRANT
CEREVEL THERAPEUTC HOLDN EQY WARRANT CEREW
Chief Financial Officer
Holding Value $1.42M 78,534 shares
Last Trade
Oct 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 78,534 shares
$1.64
$18.06
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 27, 2020 Sale
No data
No data
$44.96
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $5.34k 25,512 shares
Last Trade
May 15, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$50k 5,000 shares
$10.00
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $6.39k 30,512 shares
Last Trade
May 15, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.4k 5,000 shares
$10.27
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $26.2k 125,000 shares
Last Trade
May 15, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.4k 5,000 shares
$10.27
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $5.34k 25,512 shares
Last Trade
Apr 15, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$60.6k 5,000 shares
$12.11
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $6.39k 30,512 shares
Last Trade
Apr 15, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$60.7k 5,000 shares
$12.14
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $27.2k 130,000 shares
Last Trade
Apr 15, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$60.7k 5,000 shares
$12.14
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $5.34k 25,512 shares
Last Trade
Mar 15, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$50k 5,000 shares
$10.00
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $6.39k 30,512 shares
Last Trade
Mar 15, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.7k 5,000 shares
$9.74
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $28.3k 135,000 shares
Last Trade
Mar 15, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.7k 5,000 shares
$9.74
$0.21
Sangamo Therapeutics
Sangamo Therapeutics SGMO
EVP & Chief Financial Officer
Holding Value $5.34k 25,512 shares
Last Trade
Mar 01, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$50k 5,000 shares
$10.00
$0.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up